IX Biopharma News

General Announcement-Press Release - New Study Demonstrates that SL-NAD+ Delivers NAD+ into Cells

Sep 1 19:12 ET

Financial Statements and Related Announcement-Full Yearly Results

Aug 23 06:02 ET

General Announcement-Press Release - New Study Highlights CBD Wafer's Potential in Kidney Failure Patients

Aug 12 06:50 ET

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Changes in Interest by Substantial Shareholder - Anson Properties Pte. Ltd.

Jul 24 05:51 ET

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

Jul 24 05:47 ET

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

Jul 24 05:43 ET

IX Biopharma: REPL-Rights-Voluntary

Jul 22 07:57 ET

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

Jul 22 07:44 ET

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

Jul 22 07:41 ET

REPL-General Announcement-Issue and Listing of the Rights Shares and the Warrants

Jul 22 05:39 ET

General Announcement-Issue and Listing of the Rights Shares and the Warrants

Jul 19 06:16 ET

IX Biopharma: General Announcement-Notice From Undertaking Shareholder Anson Properties Pte. Ltd.

Jul 15 05:44 ET

IX Biopharma: General Announcement-Press Release - Breakthrough Sublingual Wafers Raise NAD+ Levels, Enhance Well-Being in Human Trial

Jul 9 06:57 ET

IX Biopharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Albert Ho Shing Tung

Jul 2 07:22 ET

IX Biopharma: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer-Disclosure of Interest/ Changes in Interest of Director - Eddy Lee Yip Hang

Jul 2 07:18 ET

IX Biopharma: General Announcement-Proposed Renounceable Non-Underwritten Rights Cum Warrants Issue-Despatch of Notification and Forms

Jul 1 05:55 ET

IX Biopharma: REPL-Rights-Voluntary

Jun 26 06:26 ET

IX Biopharma: General Announcement-Notice of Adjustment to Conversion Price of 9% Convertible Bonds Principal Amount S$2 Million

Jun 18 05:56 ET

IX Biopharma: REPL-Rights-Voluntary

Jun 18 05:53 ET

IX Biopharma: REPL-Rights-Voluntary

Jun 11 00:04 ET